27th Annual Pharmaceutical
and Medical Device Ethics
and Compliance Congress

October 13-16, 2026

Hybrid Onsite Conference & Internet Event — Live and Archived
Washington Hilton
Washington, DC

Follow Pharma Congress on:  


Preeya Noronha Pinto, JD

Partner, DLA Piper; Fmr Acting General Counsel, US Department of Health and Human Services, Washington, DC

Kenneth A. Polite, Jr, JD

Partner & Global Co-leader, White Collar Defense, Sidley Austin LLP; Fmr Assistant Attorney General, Criminal Division, US DOJ, Washington, DC

David J. Scott, MS

Managing Director, Forensic & Integrity Services, EY; Fmr Assistant Director, Counterterrorism, & Head, Operations Branch, National Cyber Investigative Joint Task Force, FBI, Leesburg, VA

Diane Seol, JD

Of Counsel, Choate Hall & Stewart; Fmr Assistant United States Attorney, Affirmative Civil Enforcement Unit, US Attorney’s Office, District of Massachusetts, Boston, MA

Michael L. Shaw, JD

Global Head of Compliance, Privacy and Risk, ZS; Fmr VP & CO, GlaxoSmithKline; Fmr Senior Counsel, OIG US HHS, Princeton, NJ

Amanda Strachan, JD

Partner, WilmerHale; Fmr AUSA & Chief, Criminal Division, US Attorney’s Office, District of Massachusetts, US DOJ, Boston, MA

Julie K. Taitsman, MD, JD

Managing Director, BDO, US; Fmr CMO, HHS Office of Inspector General; Fmr Special Counsel, US Senate Committee on Finance, Washington, DC

Jane H. Yoon, JD

Partner, Litigation Department, Paul Hastings; Fmr Assistant United States Attorney, US Attorney’s Office, New Jersey, New York, NY


COMPLIANCE EXPERTS, ADVISORS AND COUNSEL

Warren T. Allen II, JD

Principal, Miles & Stockbridge, Washington, DC

David Amendola

Director, Life Sciences, Resolution Economics; Fmr Global Compliance, ConvaTec, New York, NY

Eliza L. Andonova, JD

Partner, Global Regulatory, Hogan Lovells Cadwalader, Washington, DC

Minna Bak, MBA

Director, HELIO, Boston, MA

Brett Barlag, MBA

Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY

Samantha Barrett Badlam, JD

Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC

Yogesh Bahl, MBA

Practice Leader, Resolution Life Sciences; CFO & Head of Investor Relations, IACTA, New York, NY

David M. Blank, JD

Partner, Arnall, Golden, Gregory; Fmr Senior Counsel, HHS; Fmr Special AUSA, Southern District Mississippi, Washington, DC

Craig B. Bleifer, JD

Partner, McGuire Woods; Fmr Corporate VP, GC North America; Novo Nordisk, New York, NY

Brian A. Bohnenkamp, MHA, JD

Partner, FDA and Life Sciences, King & Spalding, Washington, DC

Eric Bolesh

Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

Mary Capizzi, JD, MBA

Partner, Faegre Drinker; General Counsel, International Pharmaceutical & Medical Device Privacy Consortium, Washington, DC

Jennifer Ceglinski, JD, CFE

Manager, Forensic & Integrity Services, EY, Charlotte, NC

Matthew Chandler, JD

Director, Epsilon Life Sciences, Richmond, VA

Michael Clarke, JD, CCEP, NACD.DC®

Principal, Jaeger-Plymouth; Retired VP, Deputy GC & Global CCO, ConvaTec, Bridgewater, NJ

Chris Cobourn, MS

Managing Director, Government Programs Practice Lead, Helio Health Group, Placida, FL

Benjamin Correa, JD

Partner, Food, Drug & Medical Device, Sidley Austin, Washington, DC

Zachary Coseglia, JD

Co-Founder, Culture. Data. Ethics; Fmr VP & AGC, Monitoring, Analytics and Digital, Pfizer, Boston, MA

Layla Covington, JD

Senior Manager, Compliance Consulting, Cresen; Fmr Manager, Aggregate Spend, Genentech, Chicago, IL

Clarissa Crain

Managing Director, Deloitte, Phoenixville, PA

Kari Czeszewski, CHC

Associate, Epsilon Life Sciences, New York, NY

Jamie E. Darch, JD

Partner, HIPAA and State Data Privacy & Cybersecurity Law, Ropes & Gray, Chicago, IL

Meena Datta, JD

Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL

Mahnu V. Davar, MA, JD

Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC

Audrey DeGuarde, MSJ

Vice President, General Manager, Commercial Compliance, MediSpend, Morristown, NJ

Edward Diskant, JD

Partner, McDermott Will & Schulte; Fmr AUSA, Southern District of New York, US DOJ, New York, NY

Stefanie A. Doebler, JD

Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC

Joy Dowdle, JD

Partner, Litigation Department, Paul Hastings and Co-Chair of the Houston Office, Houston, TX

Kip Ebel, MBA

Principal, Forensic & Integrity Services, EY, New York, NY

Aurelie Ercoli, LLM, PhD

Partner, Life Sciences Practice Group, DLA Piper, US, Washington, DC

Ronnie H. Feldman

Founder & CEO, L&E: Comedians Who Improve Compliance, Chicago, IL

Alison J. Fethke, JD

Member, Epstein Becker Green; Fmr Counsel, Legal Regulatory & Compliance, AbbVie, Chicago, IL

David Fisher, MS

President, TDI Solutions; Fmr VP & General Manager, Cyber Innovations, Battelle, Washington, DC

Sara K. Frank, JD

Principal, Life Science Practice, Choate Hall & Stewart, Boston, MA

Gary F. Giampetruzzi, JD

Partner & Global Chair Life Sciences, Paul Hastings; Fmr VP & AGC, Head of Government Investigations, Pfizer, New York, NY

John Gitas, MBA

Principal, US Advisory, Healthcare and Life Sciences, KPMG, New York, NY

Noah C. Goldstein, JD

Counsel, Pharma, Biotech & Medical Device Legal, Regulatory, & Compliance, Porzio Bromberg & Newman, Westborough, MA

Anthony Greco, MBA

Managing Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA

Asha Green, JD, MPA

Director, US Compliance, Ferring; Fmr Global Head, I&C Risk Assessment & Senior Business Advisor, Indivior, Parsippany, NJ

Neeraj Gupta, MBA

President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA

Kris Hall, JD, CIPP/CIPM

Managing Director, Dovetail; Fmr VP, Chief Privacy Officer, Celgene; Fmr VP, Head of Privacy, Shire, Bridgton, ME

Kristin M. Hicks, JD

Partner, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC

Emily F. Hodge, JD

Partner, Life Science Practice, Choate, Hall & Stewart, Boston, MA

Casey J. Horton, CFE

Managing Director, Epsilon Life Sciences; Fmr Director, Compliance Operations, AbbVie, Chicago, IL

Jeff Hyre

Vice President Sales, Healthcare & Life Sciences, Global Relay, Denver, CO

Katie Jacyna

Vice President, Product Management, Helio Health Group, Denver, CO

Mark A. Jensen, JD

Partner, Special Matters and Government Investigations, King & Spalding, Washington, DC

Erin Brown Jones, MA, JD

Partner, Latham & Watkins, Washington, DC

Marci Juneau, MBA

A Founding Partner, Helio Health Group, Atlanta, GA

Kristin Graham Koehler, JD

Managing Partner, DC Office & Executive Committee Member, Sidley Austin, Washington, DC

Olivia Krzeminski, JD

Director of Compliance & Legal Research, G&M Health, Somerset, NJ

Rebekah Latchis, JD

VP, Risk Intelligence & Investigations – Office of Integrity, Privacy and Compliance, Medtronic, Washington, DC

Stephanie Lewko, CFE

Managing Director, Ankura, Washington, DC

Jeffrey Low, RPh, MHA

Director, Ankura; Fmr VP, Clinical Services, Magellan Health; Fmr Director, Medicare Services, CVS/Caremark, Phoenix, AZ

Robert Melillo, JD

Co-founder and Managing Director, G&M Health, Cocoa Beach, FL

Brook Mishler, RN, MSN

Global Director of Compliance Solutions, Life Sciences, Case IQ; Fmr Compliance Officer for the Americas, Cordis, Ontario, Canada

Tracy Mumpower

Director, Life Science Revenue, Government Pricing, HELIO; Fmr Manager, Commercial Contract Admin, King, Bristol, VA

Katherine C. Norris, MPA

Senior Managing Director, Life Sciences Compliance, Disputes & Economics, Ankura, Honolulu, HI

Daniel O’Connor

Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ

Michael T. O’Connor

Chief Executive Officer, Qordata; Angel Investor, Angel Investor Forum, New York, NY

John Poulin

Chief Technology Officer and Partner, Helio Health Group, Boston, MA

Adam T. Oakley

Senior Director, Potomac River Partners, Washington, DC

Saraswatha Lalitha Putcha, MA

Director, Product & Client Delivery, Cresen Solutions, Philadelphia, PA

John S. Rah, JD

Counsel and Head, Life Sciences Compliance Practice, Potter & Murdock, Potomac, MD

Georgia Ravitz, JD

Partner, FDA & Healthcare Regulatory, Orrick, Herrington & Sutcliffe, Washington, DC

Nikki Reeves, JD

Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC

Michael Reyes

Director, Risk & Regulatory Consulting, PwC; Fmr Analyst, Compliance Analytics, Edwards Lifesciences, Dallas, TX

Brian Riewerts, MPA

Partner, Pharmaceutical and Life Sciences Risk and Regulatory Leader, PwC, Washington, DC

Russell Rose, JD

Managing Director, Life Sciences Advisory, Deloitte, Dallas, TX

Mark Scallon, MHA

Principal, Risk Advisory, Life Sciences Consulting, Compliance and Ethics Market Leader, Baker Tilly, Richmond, VA

Russell Schaefer, MBA

Managing Director, BCG, Washington, DC

Jeffrey Scott, JD

Of Counsel, DLA Piper; Fmr Lead Compliance Counsel Digital, Pfizer, Philadelphia, PA

Kala Shankle, JD

VP, Regulatory, Healthcare Distribution Alliance; President Elect, American Society Pharmacy Law, Wash., DC

Paul Silver

Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA

Emily (Jaffe) Singh

Partner, Global Spend Transparency Practice Leader, PwC, Chicago, IL

Laura A. Skinner, MBA

Managing Director, Life Sciences Consulting, Paul Hastings; Managing Director, Rare Disease Compliance Consortium, New York, NY

Ravneet Talwar, MBA

Senior Manager, Life Sciences & Healthcare Consulting Group, Paul Hastings, New York, NY

Stephanie Trunk, JD

Partner, Life Science Practice Group, Arent Fox Schiff; Fmr Legal Counsel, Catalyst Health Solutions, Washington, DC

Brian Van Hoy, RPh

Vice President of Compliance, G&M Health; Fmr Director Compliance & Ethics, Eli Lilly, Somerset, NJ

L. Stephan Vincze, JD, LLM, MBA

President & CEO, TRESTLE Compliance; Fmr SVP & CCO, Warner Chilcot; Fmr VP & CCO, TAP, Boston, MA

Erin Wagenberg, CIPP/US, CIPP/E, CIPT

Director, Dovetail Consulting Group; Fmr Deputy Privacy Officer, Deloitte Global, Atlanta, GA

Shannon Walker

Executive Vice President, Thought Leadership & Strategy, Case IQ; Founder and President, Whistleblower Security, Ontario, Canada

Robert A. Wells, JD

Health Care Regulatory Shareholder, Chair, Health Law and Government Solutions, Baker, Donelson, Bearman, Caldwell & Berkowitz, Baltimore, MD

Sarah L. Whipple, JD

Principal, WhipEdge Solutions; Member, Rare Disease Compliance Consortium; Fmr VP, GCCO, Apellis, Needham, MA

Kelly Willenberg, MBA, DBA, CHC

Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC

Jacob Wolf, MBA

Chief Commercial Officer, Cresen Solutions, Orlando, FL

Christina Woods, MHA

Partner, Pharmaceutical and Life Sciences Risk & Regulatory Consulting, PwC, New York, NY

Heather Young, JD

Senior Director, Compliance Officer, Global Business Partner, Olympus; Fmr Philadelphia Assistant DA, Center Valley, PA

Cobun Zweifel-Keegan, JD

Managing Director, IAPP; Fmr Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC


THE PHARMA CONGRESS ANNOUNCES AN EXTRA AFTERNOON OR HALF-DAY SPECIALTY FOCUSED SESSIONS ON HIT ISSUES IN PHARMA & DEVICE COMPLIANCE!

Kick off 27th Pharma/Device Ethics & Compliance Congress with an added half-day of high-impact Specialty Sessions on Tuesday afternoon, October 13, featuring timely, expert-led deep dives on the hottest issues facing pharma and device companies today. These will include sessions on Advanced Strategies Coordinating Compliance between Medial Affairs and Commercial & Practical Case Studies in the Use of AI by Pharma and Device Company Ethics and Compliance Departments. Included with your registration, this is a valuable opportunity to gain practical insights, benchmark with peers, and arrive fully prepared for the main three-day event.



A HYBRID CONFERENCE AND INTERNET EVENT